Knowledge Hub

At Sterling, we are proud of our heritage, strong technical capabilities and compliance credentials but it’s our people and the genuine and passionate way they do business that makes us different.

Sterling manages the most complex API and API intermediate challenges from proof-of-concept to commercial manufacture, as well as Antibody Drug Conjugate (ADC) research and development bioconjugation services.

At Sterling we believe that whilst science can be complex, partnerships should be simple. That is why we have prepared a range of resources to share our team’s research and expertise, and to help you learn more about Sterling and the services we offer.

Filter Content

Knowledge Hub Articles


Sterling Expands Bioanalytical Capabilities at Deeside, UK Site


Scientist Snapshot | Jonathan Welsh, Senior Bioanalytical Scientist


Journey of an API: Pharmaceutical engineering and production


Sterling Snapshot | Alistair Henderson, Site Director

One pager

Stability of ADCs in sub-cellular fractions

One pager

Stability of ADC linker payloads in sub-cellular fractions

Technologies & Services